Axsome Therapeutics develops therapies for central nervous system disorders, with a late-stage pipeline targeting major unmet ...

New data show that blarcamesine completely rescued impaired motor function Biomarker of nerve fiber density of dopaminergic nerve cells indicating fiber regrowth in striatum with blarcamesine New ...

Researchers developed FLAV-27, an epigenetic drug that inhibits G9a to restore gene expression in Alzheimer’s models. The treatment reduced amyloid and tau, improved cognition and synaptic function, ...

LG CNS is rapidly expanding its AI Transformation (AX) business for enterprises into the pharmaceutical, biotech, and digital ...

LG CNS has taken a stake in Silicon Valley robotics startup Dexmate as the Korean technology services company moves to deploy humanoid robots in industrial work ...

Peptide conjugation techniques are advancing CNS delivery of oligonucleotides, addressing blood-brain barrier challenges and improving therapeutic outcomes.

Learning French, reading the latest Andy Weir novel, hanging out with friends for St. Patrick's Day - language is central to all these everyday activities. Seemingly effortless from childhood, ...

LG CNS Co., Ltd. and Palantir Technologies Inc. (NASDAQ: PLTR), a leading provider of AI operating systems, today announced a deepened strategic partnership aimed at accelerating AI Transformation (AX ...

Age is more than just one number. While neuroscientists used to think of cognitive aging as a single trendline, they now realize that vast individual differences require a more predictive and ...

EQT Foundation is launching a new open call for proposals under its Science Grants program, focused on breakthrough innovations to cross or modulate the blood-brain barrier (BBB) for therapeutic ...

Explore NMDA receptor modulation and its critical role in neuronal development and cognitive functions like learning and memory.

Newly formed executive team initiates global search for differentiated therapeutic assets for neurology and oncology indications, two of biopharma's largest and fastest-growing markets ...